Company

TScan Therapeutics, Inc.

TCRX · CIK 0001783328

SEC FORM 4

$0.00

Acquisition (code A) of 300,000 shares at $0.00 per share.

Reporting Person ZDRAVESKI ZORAN · Officer Title See Remarks · Transaction Code A

Traded Oct 1, 2026 · Disclosed Oct 2, 2026

Source: SEC Form 4 · 0001193125-26-412518 · filed 2026-10-02 · View filing →

SEC FORM 4

$0.00

Acquisition (code A) of 1,000,000 shares at $0.00 per share.

Reporting Person MacBeath Gavin · Officer Title Chief Executive Officer · Transaction Code A

Traded Oct 1, 2026 · Disclosed Oct 2, 2026

Source: SEC Form 4 · 0001193125-26-412521 · filed 2026-10-02 · View filing →